期刊文献+

脂肪组织异常增殖在甲状腺相关眼病中的作用 被引量:5

Effect of abnormal adipose tissue proliferation in thyroid-associated ophthalmopathy
下载PDF
导出
摘要 甲状腺相关眼病(TAO)是最常见的眼眶疾病,公认是一种自身免疫性疾病,其发病机制至今尚未完全阐明。TAO可影响患者的外貌及视功能,严重者可导致失明。脂肪组织增殖导致眼眶组织体积增加是TAO的关键病理特征之一。眼眶脂肪组织的增多能够直接导致眶压增高,眼球突出。此外,脂肪组织可作为一种新的内分泌器官,分泌多种脂肪细胞因子、生长因子及蛋白分子等,其中部分因子可能参与了TAO的发病过程。本文旨在从脂肪分化关键蛋白的表达、自噬、眼眶压力、缺氧等方面,综述脂肪组织异常增殖分化在TAO发病过程中的作用。 Thyroid-associated ophthalmopathy(TAO)is the most common orbital disease and is a specific autoimmune disorder,of which the etiology and pathogenesis is still unclear.TAO can affect the appearance and visual function of patients,and severe cases can lead to blindness.Tissue currently considered excessive expansion due to orbital fat is formed of one of the key pathological features TAO.The increase of orbital adipose tissue can directly lead to increased retrobulbar pressures and eyeball protrusion.As a new endocrine organ,adipose tissue can secrete a variety of adipocytokines,growth factors and protein molecules,some of which may be involved in the pathogenesis of TAO.The role of abnormal adipose tissue proliferation of TAO is reviewed from the expression of key proteins of adipose differentiation,autophagy,retrobulbar pressure and hypoxia.
作者 刘薇 马超 李昊宇 陈兰 袁善思 李凯军 Wei Liu;Chao Ma;Hao-Yu Li;Lan Chen;Shan-Si Yuan;Kai-Jun Li(Guangxi Medical University,Nanning 530021,Guangxi Zhuang Autonomous Region,China;The First Affiliated Hospital of Guangxi Medical University,Nanning 530021,Guangxi Zhuang Autonomous Region,China)
出处 《国际眼科杂志》 CAS 北大核心 2019年第11期1877-1880,共4页 International Eye Science
基金 国家自然科学基金资助项目(No.81360152) 广西自然科学基金资助项目(No.2018JJA140588)~~
关键词 甲状腺相关性眼病 GRAVES眼病 脂肪细胞 发病机制 thyroid-associated ophthalmopathy Graves’ophthalmopathy adipocyte pathogenesis
  • 相关文献

参考文献3

二级参考文献62

  • 1王莉菲,吴中耀,杨华胜,颜建华,毛羽翔,陈智聪.甲状腺相关眼病患者眼眶前脂肪细胞的培养及分化[J].中山大学学报(医学科学版),2005,26(3):351-353. 被引量:9
  • 2Shao D, Lazar MA. Peroxisome proliferator activated receptor gamma, CCAA T/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation. J Biol Chem,1997, 272:21473-21478.
  • 3Adelmant G, Gilbert JD, Freytag SO. Human translocation liposarcoma-CCAAT/enhancer binding protein (C/EBP) homologous protein (TLS-CHOP) oncoprotein prevents adipocyte differentiation by directly interfering with C/EBPbeta function. J Biol Chem, 1998,273:15574-15581.
  • 4Lin FT, Lane MD. CCAA T/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci U S A, 1994,91: 8757-8761.
  • 5Freytag SO, Paielli DL, Gilbert JD. Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev , 1994, 8:1654-1663.
  • 6Wang ND, Finegold MJ, Bradley A, et al. Impaired energy homeostasis in C/EBPα knockout mice. Science, 1995, 269: 1108-1112.
  • 7Tanaka T, Yoshida N, Kishimoto T, et al. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene.EMBO J, 1997, 16:7432-7443.
  • 8Cowherd RM, Lyle RE, McGehee RE Jr. Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol, 1999,10:3-10.
  • 9Vazquez M, Silvestre JS, Prous JR. Experimental approaches to study PPAR gamma agonists as antidiabetic drugs. Methods Find Exp Clin Pharmacol, 2002, 24:515-523.
  • 10Rosen ED, Sarraf P, Troy AE, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell,1999, 4:611-617.

共引文献4

同被引文献30

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部